Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-23

Clinical Trial Update: Wearable Technology to Assess Gait Function in SMA and DMD

View source ↗

Summary

A completed clinical trial evaluating wearable technology to assess gait function in spinal muscular atrophy type 3 and Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy | Status: COMPLETED